This page helps innovators to understand:
- How do funding and contracting arrangements for NHS innovations change from pilot to scale-up?
- What evidence is required to secure ongoing investment and mainstream commissioning?
- What value (financial, environmental, and social) must my innovation demonstrate to sustain long-term NHS funding?
Over time, expectations shift from “does this work?” to “does this deliver sufficient value to justify continued investment?”. In practice, NHS contracts and funding arrangements can evolve in different ways depending on local context, priorities, and capacity. The stages below provide a simplified illustration rather than a linear or guaranteed progression – many innovations stall, pause, or change direction along the way.
Early stage or pilot phase
Innovations are typically introduced within the NHS through pilot programmes, grants, or time-limited procurement contracts. These are typically short contracts and are held across a small patient population or select number of implementation sites.
At this stage, commissioners want to understand whether the innovation works, whether staff are willing to adopt the innovation, and whether it improves the patient experience or operational efficiency.
Adoption phase
If the results from early-stage adoption are positive, the contracts may be expanded across further sites, such as within multiple trusts. These contracts may move from grants and exploratory partnerships to service contracts and performance-managed procurement.
During this transition, expectations around evidence increase, so the innovation must actively demonstrate the benefits it intends to yield.
Scale-up phase
Following this stage, if successful, the innovation begins to be treated as a standard NHS service, where funding comes from core commissioning or trust budgets and contracts become long-term. Commissioners will continue to assess whether the innovation delivers value, whether it outperforms existing care models, and whether it is financially sustainable at scale.
Overall, funding and contracting expectations for NHS innovations evolve as they move from pilot to adoption and scale-up, with increasing focus on demonstrating value, impact, and sustainability. Early stages are often supported by short-term funding or external grants, while later stages require stronger evidence and transition into mainstream commissioning and formal procurement routes. At scale, innovations must show long-term financial, environmental, and social value to justify continued investment.